Efficacy and Safety of Tofacitinib in Anti–Melanoma Differentiation–Associated 5 Gene Antibody–Positive Dermatomyositis

Overview of attention for article published in Journal of Clinical Rheumatology, July 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#21 of 2,123)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 68 X posts from 47 X users, with an upper bound of 39,311 followers.

RT @JRheumatology: 👉Efficacy and safety of tofacitinib for the treatment of anti-MDA5 antibody-positive #Dermatomyositis https://t.co/D5R6Q…

RT @JRheumatology: 👉The Vast Majority of Patients With #Fibromyalgia Have a Straight Neck Observed on a Lateral View Radiograph of the Cerv…

RT @JRheumatology: 👉Efficacy and safety of tofacitinib for the treatment of anti-MDA5 antibody-positive #Dermatomyositis https://t.co/D5R6Q…

RT @JRheumatology: 👉The Vast Majority of Patients With #Fibromyalgia Have a Straight Neck Observed on a Lateral View Radiograph of the Cerv…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 64 additional X posts.